Marker Therapeutics, Inc. (MRKR)
2.00
-0.07
(-3.38%)
USD |
NASDAQ |
Jan 09, 16:00
2.05
+0.05
(+2.50%)
After-Hours: 20:00
Marker Therapeutics Total Liabilities (Quarterly): 3.346M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 137.50M |
| Viridian Therapeutics, Inc. | 74.17M |
| Neurocrine Biosciences, Inc. | 1.262B |
| Kiniksa Pharmaceuticals International Plc | 176.95M |
| AIM ImmunoTech, Inc. | 11.57M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 21.73M |
| Shareholders Equity (Quarterly) | 18.39M |
| Current Ratio | 6.496 |